<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10726608</article-id>
    <article-id pub-id-type="pmid">38105215</article-id>
    <article-id pub-id-type="publisher-id">5615</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-023-05615-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title><italic>TCGAplot</italic>: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Liao</surname>
          <given-names>Chenqi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Xiong</given-names>
        </name>
        <address>
          <email>wangxiong@tjh.tjmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00p991c53</institution-id><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>483</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>12</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Pan-cancer analysis examines both the commonalities and heterogeneity among genomic and cellular alterations across numerous types of tumors. Pan-cancer analysis of gene expression, tumor mutational burden (TMB), microsatellite instability (MSI), and tumor immune microenvironment (TIME), and methylation becomes available based on the multi-omics data from The Cancer Genome Atlas Program (TCGA). Some online tools provide analysis of gene and protein expression, mutation, methylation, and survival for TCGA data. However, these online tools were either Uni-functional or were not able to perform analysis of user-defined functions. Therefore, we created the <italic>TCGAplot</italic> R package to facilitate perform pan-cancer analysis and visualization of the built-in multi-omic TCGA data.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2"><italic>TCGAplot</italic> provides several functions to perform pan-cancer paired/unpaired differential gene expression analysis, pan-cancer correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation. Functions for visualization include paired/unpaired boxplot, survival plot, ROC curve, heatmap, scatter, radar chart, and forest plot. Moreover, gene set based pan-cancer and tumor specific analyses were also available. Finally, all these built-in multi-omic data could be extracted for implementation for user-defined functions, making the pan-cancer analysis much more convenient.\</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">We developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. The source code and pre-built package are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12859-023-05615-3.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>TCGAplot</kwd>
      <kwd>TCGA</kwd>
      <kwd>Pan-cancer analysis</kwd>
      <kwd>Visualization</kwd>
      <kwd>User-defined function</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>
        </funding-source>
        <award-id>2021141</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wang</surname>
            <given-names>Xiong</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par15">Cancer is a major public health problem and leading death causes worldwide, with increasing new cases and deaths each year [<xref ref-type="bibr" rid="CR1">1</xref>]. Tumor occurrence and progression are accompanied by dysregulation of oncogene and tumor suppressor genes partially caused by mutation, promoter and gene body methylation [<xref ref-type="bibr" rid="CR2">2</xref>]. Immune escape is one of the most essential hallmarks of cancer cells which evade immune surveillance via disrupt the crosstalk with immune cells within the tumor microenvironment (TME). TME and tumor immune microenvironment (TIME) attract much attention in cancer research area, and strategies targeting TME have emerged as promising approaches for cancer treatment [<xref ref-type="bibr" rid="CR3">3</xref>]. Advances in multi-omics technologies enable us to access multi-layer information from the genome, transcriptome, proteome, metabolome, and epigenome, fueling the development of cancer precision medicine [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
    <p id="Par16">The Cancer Genome Atlas (TCGA) is one of the largest collections of multi-omics data involving 33 different types of cancer for more than 20 000 samples, including exome sequencing, RNA sequencing, microRNA sequencing, copy number variation, proteome and methylome [<xref ref-type="bibr" rid="CR5">5</xref>]. Several online tools have been developed to provide bioinformatic analysis of TCGA data. Tang et al. [<xref ref-type="bibr" rid="CR6">6</xref>] developed the web server GEPIA2 to perform gene expression quantification at both pan-cancer level and a specific cancer subtype manner. The cBioPortal (<ext-link ext-link-type="uri" xlink:href="https://www.cbioportal.org/">https://www.cbioportal.org/</ext-link>) for Cancer Genomics contains data sets from numerous cancer studies including TCGA, and enables researchers to explore genetic alterations per gene and sample [<xref ref-type="bibr" rid="CR7">7</xref>]. Kaplan–Meier plotter (<ext-link ext-link-type="uri" xlink:href="http://kmplot.com/analysis/">http://kmplot.com/analysis/</ext-link>) provides pan-cancer survival analysis [<xref ref-type="bibr" rid="CR8">8</xref>]. Gene Set Cancer Analysis (GSCA, <ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/GSCA/">http://bioinfo.life.hust.edu.cn/GSCA/</ext-link>#/) provides gene set cancer analysis for TCGA data, including genomic, pharmacogenomic, and immunogenomic gene sets [<xref ref-type="bibr" rid="CR9">9</xref>]. TIMER2.0 is a web server for immune infiltration across TCGA cancers [<xref ref-type="bibr" rid="CR10">10</xref>]. MethSurv (<ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/methsurv/">https://biit.cs.ut.ee/methsurv/</ext-link>) provides a web tool to perform survival analysis using TCGA methylome data [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition to these online website tools, some R packages have been developed for TCGA data download, genomic and expressive analysis, such as TCGAbiolinks and IBOR [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, an integrative R package for pan-cancer expression and correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation, is not available yet. Therefore, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA data named <italic>TCGAplot</italic>.</p>
    <sec id="Sec2">
      <title>Implementation</title>
      <p id="Par17">The source code of <italic>TCGAplot</italic> R package is public available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>. A pre-built version (v4.0.0) could be downloaded (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip">https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip</ext-link>) and installed quickly. A detailed vignette is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd">https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec3">
    <title>Results</title>
    <sec id="Sec4">
      <title>Data preparation</title>
      <p id="Par18">The integrated built-in data in <italic>TCGAplot</italic> R package include TPM (transcripts per million) expression matrix, tumor mutational burden (TMB), microsatellite instability (MSI), immune cell ratio, immune score, promoter methylation, and meta information (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of built-in data in <italic>TCGAplot</italic> R package. Both paired and unpaired TPM matrixes were included. Meta, TMB, MSI, promoter methylation, immune cell ratio, and immune scores were also included in this data. All these built-in data could be extracted for user-defined functions</p></caption><graphic xlink:href="12859_2023_5615_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">The expression TPM matrix was downloaded from TCGA (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>) using the TCGAbiolinks R package (v2.28.4) with GDCquery, GDCdownload, and GDCprepare functions [<xref ref-type="bibr" rid="CR12">12</xref>]. Duplicated samples were removed randomly. Genes with TPM value of 0 across all samples were excluded, and the final TPM matrix with protein-coding genes was shown as log2(TPM + 1) accompanied with cancer type and group (tumor, normal) information. The somatic mutation and DNA methylation beta value data were downloaded with the TCGAbiolinks R package. The probes within the TSS1500-island region was selected as promoter region. The MSI value of TCGA patients were downloaded using the cBioPortalData R package (v2.12.0) [<xref ref-type="bibr" rid="CR14">14</xref>]. The immune cell ratio was downloaded from The Immune Landscape of Cancer (<ext-link ext-link-type="uri" xlink:href="https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a">https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a</ext-link>). The immune scores, including ESTIMATE, Immune, and Stromal scores, were calculated using the estimate R package (v1.0.13) based on the TPM matrix [<xref ref-type="bibr" rid="CR15">15</xref>]. The gene lists for ‘stromal signature’ and ‘immune signature’ were summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
    </sec>
    <sec id="Sec5">
      <title>Pan-cancer expression analysis</title>
      <p id="Par20">Pan-cancer expression analysis includes unpaired tumor-normal box plot across 33 types of TCGA cancers (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a) and paired tumor-normal box plot across 15 types of TCGA cancers with more than 20 pairs of samples (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b) using pan_boxplot and pan_paired_boxplot functions respectively. Moreover, pan-cancer expression of a single gene across 33 types of tumor samples (without normal samples) could be achieved by using pan_tumor_boxplot function (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c).<fig id="Fig2"><label>Fig. 2</label><caption><p>Pan-cancer expression analysis. <bold>a</bold> Pan-cancer expression of KLF7 with the function of “pan_boxplot(gene = "KLF7", palette = "jco", legend = "right")”. <bold>b</bold> Pan-cancer expression of KLF7 of paired samples with the function of “pan_paired_boxplot (gene = "KLF7", palette = "jco", legend = "right")”. Only 15 types of cancers with more than 20 paired samples in TCGA were included. <bold>c</bold> Pan-cancer expression of KLF7 across 33 types of tumor samples (without normal samples) with the function of “pan_tumor_boxplot("KLF7")”. ns, not significant; *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001</p></caption><graphic xlink:href="12859_2023_5615_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>Pan-cancer correlation analysis</title>
      <p id="Par21">We also provide functions to analyze the correlation between single gene expression and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b).<fig id="Fig3"><label>Fig. 3</label><caption><p>Correlation between gene expression and TMB, and MSI. <bold>a</bold> Correlation between expression of KLF7 and TMB with the function “gene_TMB_radar("KLF7")”. KLF7 was negatively correlated with TMB in CHOL, COAD, ESCA, HNSC, KIRP, OV, and THCA, while positively correlated with TMB in SKCM. <bold>b</bold> Correlation between expression of KLF7 and MSI with the function “gene_MSI_radar("KLF7")”. KLF7 was negatively correlated with MSI in COAD, DLBC, HNSC, and STAD, while positively correlated with MSI in LUSC. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par22">Immunotherapy has revolutionized the treatment of cancer patients and rejuvenated the field of TIME. Therefore, we also provide some functions to perform the correlation between a single gene and immune-related genes, including immune checkpoint genes (ICGs) (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a), chemokine (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b), chemokine receptor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c), immune stimulator (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d), and immune inhibitor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e). Moreover, two color parameters, “lowcol” and “highcol”, were provided for users to define the colors of low point and high point in the heatmap respectively.<fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between a single gene and immune-related genes. <bold>a</bold> Correlation between KLF7 and ICGs with function “gene_checkpoint_heatmap("KLF7", method = "pearson", lowcol = "blue", highcol = "red")”. <bold>b</bold> Correlation between KLF7 and chemokines with function “gene_chemokine_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and chemokine receptors with function “gene_receptor_heatmap("KLF7")”. <bold>d</bold> Correlation between KLF7 and immune stimulators with function “gene_immustimulator_heatmap("KLF7")”. <bold>e</bold> Correlation between KLF7 and immune inhibitors with function “gene_immuinhibitor_heatmap("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par23">Moreover, correlation between gene expression and immune infiltration could be analyzed, including immune cell ratio (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a), immune score (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b, c).<fig id="Fig5"><label>Fig. 5</label><caption><p>Correlation a single gene and immune infiltration. <bold>a</bold> Correlation between KLF7 and immune cell ratio with function “gene_immucell_heatmap("KLF7")”. <bold>b</bold> Correlation between KLF7 and immune score displayed by heatmap with function “gene_immunescore_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and immune score displayed by triangle with function “gene_immunescore_triangle("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Pan-cancer cox regression analysis</title>
      <p id="Par24">The Cox regression model is used for survival analyses in clinical research by estimating the hazard ratio (HR) of a given endpoint correlated with a specific risk factor, such as the expression of a single gene. We provide function to perform pan-cancer cox regression analysis with or without age adjustment and visualization by forest plot (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a, b).<fig id="Fig6"><label>Fig. 6</label><caption><p>Pan-cancer Cox regression analysis. <bold>a</bold> Pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = F)”. KLF7 acts as risk factor in CESE, HNSC, LGG, PAAD, while acts as protective factor in KIRC and READ. <bold>b</bold> Age adjusted pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = T)”. After age adjustment, KLF7 did not act as a protective factor in READ</p></caption><graphic xlink:href="12859_2023_5615_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Pan-cancer correlation analysis based on gene set</title>
      <p id="Par25">Sometimes it is a gene set (instead of a gene) that’s driving the TMB, so we also provide functions to analyze the correlation between the express of a gene set and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig7" ref-type="fig">7</xref>a, b).<fig id="Fig7"><label>Fig. 7</label><caption><p>Correlation between gene set and TMB, and MSI. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and TMB with the function “gs_TMB_radar("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and MSI with the function “gs_MSI_radar("KEGG_APOPTOSIS")”. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig7_HTML" id="MO7"/></fig></p>
      <p id="Par26">We also provide some functions to perform the correlation between a gene set and immune-related genes, including ICGs (Fig. <xref rid="Fig8" ref-type="fig">8</xref>a), chemokine (Fig. <xref rid="Fig8" ref-type="fig">8</xref>b), chemokine receptor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>c), immune stimulator (Fig. <xref rid="Fig8" ref-type="fig">8</xref>d), and immune inhibitor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>e).<fig id="Fig8"><label>Fig. 8</label><caption><p>Correlation between a gene set and immune-related genes. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and ICGs with function “gs_checkpoint_heatmap("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokines with function “gs_chemokine_heatmap("KEGG_APOPTOSIS")”. <bold>c</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokine receptors with function “gs_receptor_heatmap("KEGG_APOPTOSIS")”. <bold>d</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune stimulators with function “gs_immustimulator_heatmap("KEGG_APOPTOSIS")”. <bold>e</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune inhibitors with function “gs_immuinhibitor_heatmap("KEGG_APOPTOSIS")”</p></caption><graphic xlink:href="12859_2023_5615_Fig8_HTML" id="MO8"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Cancer type specific expression analysis</title>
      <p id="Par27">In addition to pan-cancer analysis, we have also provided numerous functions for caner type specific samples. The expression of a single gene could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>a) and paired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig9" ref-type="fig">9</xref>c, d), gender (Fig. <xref rid="Fig9" ref-type="fig">9</xref>e), and stage (Fig. <xref rid="Fig9" ref-type="fig">9</xref>f).<fig id="Fig9"><label>Fig. 9</label><caption><p>Cancer type specific expression analysis. <bold>a</bold> Expression of KLF7 in COAD with the function “tcga_boxplot("COAD","KLF7")”. <bold>b</bold> Expression of KLF7 in paired COAD samples with the function “paired_boxplot("COAD","KLF7")”. <bold>c</bold> Expression of KLF7 in COAD samples grouped by age with the function “gene_age("COAD","KLF7")”. <bold>d</bold> Expression of KLF7 in COAD samples grouped by three age groups with the function “gene_3age("COAD","KLF7")”. <bold>e</bold> Expression of KLF7 in COAD samples grouped by gender with the function “gene_gender("COAD","KLF7")”. <bold>f</bold> Expression of KLF7 in COAD samples grouped by stage with the function “gene_stage("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig9_HTML" id="MO9"/></fig></p>
      <p id="Par28">Moreover, we provided cancer type specific analysis of gene set. The expression of a gene set could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>a) and paired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig10" ref-type="fig">10</xref>c, d), gender (Fig. <xref rid="Fig10" ref-type="fig">10</xref>e), and stage (Fig. <xref rid="Fig10" ref-type="fig">10</xref>f).<fig id="Fig10"><label>Fig. 10</label><caption><p>Cancer type specific gene set analysis. <bold>a</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD with the function “gs_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>b</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in paired COAD samples with the function “gs_paired_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>c</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by age with the function “gs_age("COAD","HALLMARK_DNA_REPAIR")”. <bold>d</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by three age groups with the function “gs_3age("COAD","HALLMARK_DNA_REPAIR")”. <bold>e</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by gender with the function “gs_gender("COAD","HALLMARK_DNA_REPAIR")”. <bold>f</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by stage with the function “gs_stage("COAD","HALLMARK_DNA_REPAIR")”</p></caption><graphic xlink:href="12859_2023_5615_Fig10_HTML" id="MO10"/></fig></p>
      <p id="Par29">Tumor samples in a specific type of cancer could be further grouped by the expression of a single gene, and the differentially expressed genes (DEGs) between high-expression and low-expression groups could be identified (Fig. <xref rid="Fig11" ref-type="fig">11</xref>a) and analyzed using Gene Set Enrichment Analysis (GSEA) including GSEA-GO (Gene Ontology) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>b) and GSEA-KEGG (Kyoto Encyclopedia of Genes and Genomes) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>c).<fig id="Fig11"><label>Fig. 11</label><caption><p>DEGs analysis between high- and low-expression groups of a single gene. <bold>a</bold> Heat map showed the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_deg_heatmap("COAD","KLF7")”. <bold>b</bold> GSEA-GO analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_go("COAD","KLF7")”, and the top 5 GO pathways were shown. <bold>c</bold> GSEA-KEGG analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_kegg("COAD","KLF7")”, and the top 5 KEGG pathways were shown</p></caption><graphic xlink:href="12859_2023_5615_Fig11_HTML" id="MO11"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Cancer type specific diagnostic analysis</title>
      <p id="Par30">Receiver operating characteristic (ROC) curve and the area under the curve (AUC) were widely used to examine the sensitivity and specificity of a diagnostic model. We provide function to draw the ROC curve and calculate the AUC of a diagnostic model using the expression of a single gene in a specific type of cancer. An example was shown for KLF7 in CHOL (Fig. <xref rid="Fig12" ref-type="fig">12</xref>a), HNSC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>b), and UCEC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>c).<fig id="Fig12"><label>Fig. 12</label><caption><p>Cancer type specific diagnostic analysis. <bold>a</bold> ROC curve of the diagnostic model based on the expression of KLF7 in CHOL with function “tcga_roc("CHOL","KLF7")”. <bold>b</bold> ROC curve of the diagnostic model based on the expression of KLF7 in HNSC with function “tcga_roc("HNSC","KLF7")”. <bold>c</bold> ROC curve of the diagnostic model based on the expression of KLF7 in UCEC with function “tcga_roc("UCEC","KLF7")”. KLF7 showed significant diagnostic values in these types of cancer</p></caption><graphic xlink:href="12859_2023_5615_Fig12_HTML" id="MO12"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Cancer type specific correlation analysis</title>
      <p id="Par31">We provide correlation analysis in a specific type of cancer, including gene–gene (Fig. <xref rid="Fig13" ref-type="fig">13</xref>a, b), gene-methylation (Fig. <xref rid="Fig13" ref-type="fig">13</xref>c) correlation analysis. Moreover, for the correlated genes, GO enrichment analysis (Fig. <xref rid="Fig13" ref-type="fig">13</xref>d) is also available.<fig id="Fig13"><label>Fig. 13</label><caption><p>Cancer type specific correlation analysis. <bold>a</bold> Correlation between KLF4 and KLF7 in COAD with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "F")”. <bold>b</bold> Correlation between KLF4 and KLF7 in COAD showing the density of gene expression with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "T")”. <bold>c</bold> Correlation between KLF7 expression and promoter methylation in COAD with function “gene_methylation_scatter("COAD","KLF7")”. <bold>d</bold> Expression heat map and enriched GO pathways of significantly positive or negative correlated genes with KLF7 in COAD with function “gene_coexp_heatmap("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig13_HTML" id="MO13"/></fig></p>
    </sec>
    <sec id="Sec12">
      <title>Cancer type specific survival analysis</title>
      <p id="Par32">Survival analysis base on the expression (Fig. <xref rid="Fig14" ref-type="fig">14</xref>a) or methylation (Fig. <xref rid="Fig14" ref-type="fig">14</xref>b) level of a single gene in a specific type of cancer could be performed.<fig id="Fig14"><label>Fig. 14</label><caption><p>Cancer type specific survival analysis. <bold>a</bold> KM plot for the survival analysis of KLF7 expression in COAD with function “tcga_kmplot("COAD","KLF7")”. <bold>b</bold> KM plot for the survival analysis of KLF7 methylation in COAD with function “methy_kmplot("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig14_HTML" id="MO14"/></fig></p>
    </sec>
    <sec id="Sec13">
      <title>Network construction</title>
      <p id="Par33">Users can also depict the linkages of a single gene or a gene set and GO terms or KEGG pathways as a network using the gene_network_go (Fig. <xref rid="Fig15" ref-type="fig">15</xref>a) and gene_network_kegg (Fig. <xref rid="Fig15" ref-type="fig">15</xref>b) functions.<fig id="Fig15"><label>Fig. 15</label><caption><p>Network construction. <bold>a</bold> Cnetplot was used to depict the linkages of a gene set and GO terms as a network with function of “gene_network_go(c("LAMA3","LAMC2","TNC","OSMR"))”. <bold>b</bold> Cnetplot was used to depict the linkages of a gene set and KEGG pathways as a network with function of “gene_network_kegg(c("LAMA3","LAMC2","TNC","OSMR"))”</p></caption><graphic xlink:href="12859_2023_5615_Fig15_HTML" id="MO15"/></fig></p>
    </sec>
    <sec id="Sec14">
      <title>Built-in data extraction</title>
      <p id="Par34">All built-in data in our package could be extracted for user-defined functions, including TPM expression matrix, TMB, MSI, immune cell ratio, immune score, promoter methylation, and meta information with functions listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Therefore, users could perform their user-defined functions to make more unique analysis with TCGA multi-omics data.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of functions to extract built-in data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Function name</th><th align="left">Function</th></tr></thead><tbody><tr><td align="left">get_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer in TCGA. eg, get_tpm("COAD")</td></tr><tr><td align="left">get_paired_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer with paired samples (n &gt; 20) in TCGA. eg, get_paired_tpm("COAD")</td></tr><tr><td align="left">get_meta(cancer)</td><td align="left">Extract the clinical information of a specific type of cancer in TCGA. eg, get_meta("COAD")</td></tr><tr><td align="left">get_tmb()</td><td align="left">Extract the TMB matrix of all samples in TCGA</td></tr><tr><td align="left">get_msi()</td><td align="left">Extract the MSI matrix of all samples in TCGA</td></tr><tr><td align="left">get_methy()</td><td align="left">Print the link of the whole methylation matrix for users to download</td></tr><tr><td align="left">get_promoter_methy()</td><td align="left">Extract promoter methylation of a specific type of tumor</td></tr><tr><td align="left">get_immu_ratio()</td><td align="left">Extract the immune cell ratio of all samples in TCGA</td></tr><tr><td align="left">get_immuscore()</td><td align="left">Extract the immune score of all samples in TCGA</td></tr><tr><td align="left">get_cancers()</td><td align="left">Return the sample summary of 33 types of cancer in TCGA</td></tr><tr><td align="left">get_paired_cancers()</td><td align="left">Return the sample summary of 15 types of cancer containing more than 20 paired samples in TCGA</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Conclusion</title>
    <p id="Par35"><italic>TCGAplot</italic> provides a user-friendly interface for analyzing TCGA pan-cancer multi-omics data and uses visualization techniques to enable users explore the commonalities and heterogeneity across numerous types of tumors. Concretely, several functions have been developed to perform pan-cancer paired/unpaired expression analysis, correlation analysis, survival analysis, as well as user-defined function analysis. Overall, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec16">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2023_5615_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1:</bold> The gene lists for “stromal signature” and “immune signature”.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>TME</term>
        <def>
          <p id="Par4">Tumor microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TIME</term>
        <def>
          <p id="Par5">Tumor immune microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p id="Par6">The cancer genome atlas</p>
        </def>
      </def-item>
      <def-item>
        <term>TPM</term>
        <def>
          <p id="Par7">Transcripts per million</p>
        </def>
      </def-item>
      <def-item>
        <term>TMB</term>
        <def>
          <p id="Par8">Tumor mutational burden</p>
        </def>
      </def-item>
      <def-item>
        <term>MSI</term>
        <def>
          <p id="Par9">Microsatellite instability</p>
        </def>
      </def-item>
      <def-item>
        <term>HR</term>
        <def>
          <p id="Par10">Hazard ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>DEGs</term>
        <def>
          <p id="Par11">Differentially expressed genes</p>
        </def>
      </def-item>
      <def-item>
        <term>GSEA</term>
        <def>
          <p id="Par12">Gene set enrichment analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>GO</term>
        <def>
          <p id="Par13">Gene ontology</p>
        </def>
      </def-item>
      <def-item>
        <term>KEGG</term>
        <def>
          <p id="Par14">Kyoto encyclopedia of genes and genomes</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>XW wrote the software and the manuscript. CL prepared the figures. The author read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research was funded by Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2021141 to XW).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The source code is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par36">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par37">Not applicable.</p>
    </notes>
    <notes id="FPar4">
      <title>Availability and requirements</title>
      <p id="Par39">
        <list list-type="bullet">
          <list-item>
            <p id="Par40">Project name TCGAplot</p>
          </list-item>
          <list-item>
            <p id="Par41">Project home page <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link></p>
          </list-item>
          <list-item>
            <p id="Par42">Operating system(s) Platform independent</p>
          </list-item>
          <list-item>
            <p id="Par43">Programming language R</p>
          </list-item>
          <list-item>
            <p id="Par44">License MIT</p>
          </list-item>
          <list-item>
            <p id="Par45">Other requirements: R 2.1.0 or higher</p>
          </list-item>
          <list-item>
            <p id="Par46">Any restrictions to use by non-academics: license needed</p>
          </list-item>
        </list>
      </p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par38">The authors declare that there is no conflict of interest.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2022</article-title>
        <source>CA Cancer J Clin</source>
        <year>2022</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>7</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21708</pub-id>
        <?supplied-pmid 35020204?>
        <pub-id pub-id-type="pmid">35020204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zwierenga</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>van Veggel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>van den Berg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Groen</surname>
            <given-names>HJM</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Groves</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Smit</surname>
            <given-names>EF</given-names>
          </name>
          <name>
            <surname>Hiltermann</surname>
            <given-names>TJN</given-names>
          </name>
          <name>
            <surname>de Langen</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments</article-title>
        <source>Cancer Treat Rev</source>
        <year>2023</year>
        <volume>120</volume>
        <fpage>102628</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ctrv.2023.102628</pub-id>
        <?supplied-pmid 37797348?>
        <pub-id pub-id-type="pmid">37797348</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bejarano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jordao</surname>
            <given-names>MJC</given-names>
          </name>
          <name>
            <surname>Joyce</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic targeting of the tumor microenvironment</article-title>
        <source>Cancer Discov</source>
        <year>2021</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>933</fpage>
        <lpage>959</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-20-1808</pub-id>
        <?supplied-pmid 33811125?>
        <pub-id pub-id-type="pmid">33811125</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zuo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jing</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence-based multi-omics analysis fuels cancer precision medicine</article-title>
        <source>Semin Cancer Biol</source>
        <year>2023</year>
        <volume>88</volume>
        <fpage>187</fpage>
        <lpage>200</lpage>
        <pub-id pub-id-type="doi">10.1016/j.semcancer.2022.12.009</pub-id>
        <?supplied-pmid 36596352?>
        <pub-id pub-id-type="pmid">36596352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Cancer Genome Atlas Research N</collab>
          <name>
            <surname>Weinstein</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Collisson</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Ozenberger</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shmulevich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>10</issue>
        <fpage>1113</fpage>
        <lpage>1120</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2764</pub-id>
        <pub-id pub-id-type="pmid">24071849</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>W1</issue>
        <fpage>W556</fpage>
        <lpage>W560</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz430</pub-id>
        <?supplied-pmid 31114875?>
        <pub-id pub-id-type="pmid">31114875</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cerami</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Sumer</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Aksoy</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Heuer</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title>
        <source>Cancer Discov</source>
        <year>2012</year>
        <volume>2</volume>
        <issue>5</issue>
        <fpage>401</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id>
        <?supplied-pmid 22588877?>
        <pub-id pub-id-type="pmid">22588877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanczky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gyorffy</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Web-based survival analysis tool tailored for medical research (KMplot): development and Implementation</article-title>
        <source>J Med Internet Res</source>
        <year>2021</year>
        <volume>23</volume>
        <issue>7</issue>
        <fpage>e27633</fpage>
        <pub-id pub-id-type="doi">10.2196/27633</pub-id>
        <?supplied-pmid 34309564?>
        <pub-id pub-id-type="pmid">34309564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>YR</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XW</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AY</given-names>
          </name>
        </person-group>
        <article-title>GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels</article-title>
        <source>Brief Bioinform</source>
        <year>2023</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>bbac558</fpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbac558</pub-id>
        <?supplied-pmid 36549921?>
        <pub-id pub-id-type="pmid">36549921</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>TIMER20 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>W1</issue>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <?supplied-pmid 32442275?>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Modhukur</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Iljasenko</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Metsalu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lokk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Laisk-Podar</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vilo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data</article-title>
        <source>Epigenomics</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>277</fpage>
        <lpage>288</lpage>
        <pub-id pub-id-type="doi">10.2217/epi-2017-0118</pub-id>
        <?supplied-pmid 29264942?>
        <pub-id pub-id-type="pmid">29264942</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Colaprico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garofano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cava</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garolini</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sabedot</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Malta</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Pagnotta</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Castiglioni</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>8</issue>
        <fpage>e71</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1507</pub-id>
        <?supplied-pmid 26704973?>
        <pub-id pub-id-type="pmid">26704973</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures</article-title>
        <source>Front Immunol</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>687975</fpage>
        <pub-id pub-id-type="doi">10.3389/fimmu.2021.687975</pub-id>
        <?supplied-pmid 34276676?>
        <pub-id pub-id-type="pmid">34276676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Geistlinger</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schiffer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Azhar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kodali</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Bruijn</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiomic integration of public oncology databases in bioconductor</article-title>
        <source>JCO Clin Cancer Inform</source>
        <year>2020</year>
        <volume>4</volume>
        <fpage>958</fpage>
        <lpage>971</lpage>
        <pub-id pub-id-type="doi">10.1200/CCI.19.00119</pub-id>
        <?supplied-pmid 33119407?>
        <pub-id pub-id-type="pmid">33119407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshihara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shahmoradgoli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vegesna</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Torres-Garcia</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Laird</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>DA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inferring tumour purity and stromal and immune cell admixture from expression data</article-title>
        <source>Nat Commun</source>
        <year>2013</year>
        <volume>4</volume>
        <fpage>2612</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms3612</pub-id>
        <?supplied-pmid 24113773?>
        <pub-id pub-id-type="pmid">24113773</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10726608</article-id>
    <article-id pub-id-type="pmid">38105215</article-id>
    <article-id pub-id-type="publisher-id">5615</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-023-05615-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title><italic>TCGAplot</italic>: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Liao</surname>
          <given-names>Chenqi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Xiong</given-names>
        </name>
        <address>
          <email>wangxiong@tjh.tjmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00p991c53</institution-id><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>483</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>12</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Pan-cancer analysis examines both the commonalities and heterogeneity among genomic and cellular alterations across numerous types of tumors. Pan-cancer analysis of gene expression, tumor mutational burden (TMB), microsatellite instability (MSI), and tumor immune microenvironment (TIME), and methylation becomes available based on the multi-omics data from The Cancer Genome Atlas Program (TCGA). Some online tools provide analysis of gene and protein expression, mutation, methylation, and survival for TCGA data. However, these online tools were either Uni-functional or were not able to perform analysis of user-defined functions. Therefore, we created the <italic>TCGAplot</italic> R package to facilitate perform pan-cancer analysis and visualization of the built-in multi-omic TCGA data.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2"><italic>TCGAplot</italic> provides several functions to perform pan-cancer paired/unpaired differential gene expression analysis, pan-cancer correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation. Functions for visualization include paired/unpaired boxplot, survival plot, ROC curve, heatmap, scatter, radar chart, and forest plot. Moreover, gene set based pan-cancer and tumor specific analyses were also available. Finally, all these built-in multi-omic data could be extracted for implementation for user-defined functions, making the pan-cancer analysis much more convenient.\</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">We developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. The source code and pre-built package are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12859-023-05615-3.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>TCGAplot</kwd>
      <kwd>TCGA</kwd>
      <kwd>Pan-cancer analysis</kwd>
      <kwd>Visualization</kwd>
      <kwd>User-defined function</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>
        </funding-source>
        <award-id>2021141</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wang</surname>
            <given-names>Xiong</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par15">Cancer is a major public health problem and leading death causes worldwide, with increasing new cases and deaths each year [<xref ref-type="bibr" rid="CR1">1</xref>]. Tumor occurrence and progression are accompanied by dysregulation of oncogene and tumor suppressor genes partially caused by mutation, promoter and gene body methylation [<xref ref-type="bibr" rid="CR2">2</xref>]. Immune escape is one of the most essential hallmarks of cancer cells which evade immune surveillance via disrupt the crosstalk with immune cells within the tumor microenvironment (TME). TME and tumor immune microenvironment (TIME) attract much attention in cancer research area, and strategies targeting TME have emerged as promising approaches for cancer treatment [<xref ref-type="bibr" rid="CR3">3</xref>]. Advances in multi-omics technologies enable us to access multi-layer information from the genome, transcriptome, proteome, metabolome, and epigenome, fueling the development of cancer precision medicine [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
    <p id="Par16">The Cancer Genome Atlas (TCGA) is one of the largest collections of multi-omics data involving 33 different types of cancer for more than 20 000 samples, including exome sequencing, RNA sequencing, microRNA sequencing, copy number variation, proteome and methylome [<xref ref-type="bibr" rid="CR5">5</xref>]. Several online tools have been developed to provide bioinformatic analysis of TCGA data. Tang et al. [<xref ref-type="bibr" rid="CR6">6</xref>] developed the web server GEPIA2 to perform gene expression quantification at both pan-cancer level and a specific cancer subtype manner. The cBioPortal (<ext-link ext-link-type="uri" xlink:href="https://www.cbioportal.org/">https://www.cbioportal.org/</ext-link>) for Cancer Genomics contains data sets from numerous cancer studies including TCGA, and enables researchers to explore genetic alterations per gene and sample [<xref ref-type="bibr" rid="CR7">7</xref>]. Kaplan–Meier plotter (<ext-link ext-link-type="uri" xlink:href="http://kmplot.com/analysis/">http://kmplot.com/analysis/</ext-link>) provides pan-cancer survival analysis [<xref ref-type="bibr" rid="CR8">8</xref>]. Gene Set Cancer Analysis (GSCA, <ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/GSCA/">http://bioinfo.life.hust.edu.cn/GSCA/</ext-link>#/) provides gene set cancer analysis for TCGA data, including genomic, pharmacogenomic, and immunogenomic gene sets [<xref ref-type="bibr" rid="CR9">9</xref>]. TIMER2.0 is a web server for immune infiltration across TCGA cancers [<xref ref-type="bibr" rid="CR10">10</xref>]. MethSurv (<ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/methsurv/">https://biit.cs.ut.ee/methsurv/</ext-link>) provides a web tool to perform survival analysis using TCGA methylome data [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition to these online website tools, some R packages have been developed for TCGA data download, genomic and expressive analysis, such as TCGAbiolinks and IBOR [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, an integrative R package for pan-cancer expression and correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation, is not available yet. Therefore, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA data named <italic>TCGAplot</italic>.</p>
    <sec id="Sec2">
      <title>Implementation</title>
      <p id="Par17">The source code of <italic>TCGAplot</italic> R package is public available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>. A pre-built version (v4.0.0) could be downloaded (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip">https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip</ext-link>) and installed quickly. A detailed vignette is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd">https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec3">
    <title>Results</title>
    <sec id="Sec4">
      <title>Data preparation</title>
      <p id="Par18">The integrated built-in data in <italic>TCGAplot</italic> R package include TPM (transcripts per million) expression matrix, tumor mutational burden (TMB), microsatellite instability (MSI), immune cell ratio, immune score, promoter methylation, and meta information (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of built-in data in <italic>TCGAplot</italic> R package. Both paired and unpaired TPM matrixes were included. Meta, TMB, MSI, promoter methylation, immune cell ratio, and immune scores were also included in this data. All these built-in data could be extracted for user-defined functions</p></caption><graphic xlink:href="12859_2023_5615_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">The expression TPM matrix was downloaded from TCGA (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>) using the TCGAbiolinks R package (v2.28.4) with GDCquery, GDCdownload, and GDCprepare functions [<xref ref-type="bibr" rid="CR12">12</xref>]. Duplicated samples were removed randomly. Genes with TPM value of 0 across all samples were excluded, and the final TPM matrix with protein-coding genes was shown as log2(TPM + 1) accompanied with cancer type and group (tumor, normal) information. The somatic mutation and DNA methylation beta value data were downloaded with the TCGAbiolinks R package. The probes within the TSS1500-island region was selected as promoter region. The MSI value of TCGA patients were downloaded using the cBioPortalData R package (v2.12.0) [<xref ref-type="bibr" rid="CR14">14</xref>]. The immune cell ratio was downloaded from The Immune Landscape of Cancer (<ext-link ext-link-type="uri" xlink:href="https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a">https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a</ext-link>). The immune scores, including ESTIMATE, Immune, and Stromal scores, were calculated using the estimate R package (v1.0.13) based on the TPM matrix [<xref ref-type="bibr" rid="CR15">15</xref>]. The gene lists for ‘stromal signature’ and ‘immune signature’ were summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
    </sec>
    <sec id="Sec5">
      <title>Pan-cancer expression analysis</title>
      <p id="Par20">Pan-cancer expression analysis includes unpaired tumor-normal box plot across 33 types of TCGA cancers (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a) and paired tumor-normal box plot across 15 types of TCGA cancers with more than 20 pairs of samples (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b) using pan_boxplot and pan_paired_boxplot functions respectively. Moreover, pan-cancer expression of a single gene across 33 types of tumor samples (without normal samples) could be achieved by using pan_tumor_boxplot function (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c).<fig id="Fig2"><label>Fig. 2</label><caption><p>Pan-cancer expression analysis. <bold>a</bold> Pan-cancer expression of KLF7 with the function of “pan_boxplot(gene = "KLF7", palette = "jco", legend = "right")”. <bold>b</bold> Pan-cancer expression of KLF7 of paired samples with the function of “pan_paired_boxplot (gene = "KLF7", palette = "jco", legend = "right")”. Only 15 types of cancers with more than 20 paired samples in TCGA were included. <bold>c</bold> Pan-cancer expression of KLF7 across 33 types of tumor samples (without normal samples) with the function of “pan_tumor_boxplot("KLF7")”. ns, not significant; *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001</p></caption><graphic xlink:href="12859_2023_5615_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>Pan-cancer correlation analysis</title>
      <p id="Par21">We also provide functions to analyze the correlation between single gene expression and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b).<fig id="Fig3"><label>Fig. 3</label><caption><p>Correlation between gene expression and TMB, and MSI. <bold>a</bold> Correlation between expression of KLF7 and TMB with the function “gene_TMB_radar("KLF7")”. KLF7 was negatively correlated with TMB in CHOL, COAD, ESCA, HNSC, KIRP, OV, and THCA, while positively correlated with TMB in SKCM. <bold>b</bold> Correlation between expression of KLF7 and MSI with the function “gene_MSI_radar("KLF7")”. KLF7 was negatively correlated with MSI in COAD, DLBC, HNSC, and STAD, while positively correlated with MSI in LUSC. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par22">Immunotherapy has revolutionized the treatment of cancer patients and rejuvenated the field of TIME. Therefore, we also provide some functions to perform the correlation between a single gene and immune-related genes, including immune checkpoint genes (ICGs) (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a), chemokine (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b), chemokine receptor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c), immune stimulator (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d), and immune inhibitor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e). Moreover, two color parameters, “lowcol” and “highcol”, were provided for users to define the colors of low point and high point in the heatmap respectively.<fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between a single gene and immune-related genes. <bold>a</bold> Correlation between KLF7 and ICGs with function “gene_checkpoint_heatmap("KLF7", method = "pearson", lowcol = "blue", highcol = "red")”. <bold>b</bold> Correlation between KLF7 and chemokines with function “gene_chemokine_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and chemokine receptors with function “gene_receptor_heatmap("KLF7")”. <bold>d</bold> Correlation between KLF7 and immune stimulators with function “gene_immustimulator_heatmap("KLF7")”. <bold>e</bold> Correlation between KLF7 and immune inhibitors with function “gene_immuinhibitor_heatmap("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par23">Moreover, correlation between gene expression and immune infiltration could be analyzed, including immune cell ratio (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a), immune score (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b, c).<fig id="Fig5"><label>Fig. 5</label><caption><p>Correlation a single gene and immune infiltration. <bold>a</bold> Correlation between KLF7 and immune cell ratio with function “gene_immucell_heatmap("KLF7")”. <bold>b</bold> Correlation between KLF7 and immune score displayed by heatmap with function “gene_immunescore_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and immune score displayed by triangle with function “gene_immunescore_triangle("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Pan-cancer cox regression analysis</title>
      <p id="Par24">The Cox regression model is used for survival analyses in clinical research by estimating the hazard ratio (HR) of a given endpoint correlated with a specific risk factor, such as the expression of a single gene. We provide function to perform pan-cancer cox regression analysis with or without age adjustment and visualization by forest plot (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a, b).<fig id="Fig6"><label>Fig. 6</label><caption><p>Pan-cancer Cox regression analysis. <bold>a</bold> Pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = F)”. KLF7 acts as risk factor in CESE, HNSC, LGG, PAAD, while acts as protective factor in KIRC and READ. <bold>b</bold> Age adjusted pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = T)”. After age adjustment, KLF7 did not act as a protective factor in READ</p></caption><graphic xlink:href="12859_2023_5615_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Pan-cancer correlation analysis based on gene set</title>
      <p id="Par25">Sometimes it is a gene set (instead of a gene) that’s driving the TMB, so we also provide functions to analyze the correlation between the express of a gene set and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig7" ref-type="fig">7</xref>a, b).<fig id="Fig7"><label>Fig. 7</label><caption><p>Correlation between gene set and TMB, and MSI. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and TMB with the function “gs_TMB_radar("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and MSI with the function “gs_MSI_radar("KEGG_APOPTOSIS")”. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig7_HTML" id="MO7"/></fig></p>
      <p id="Par26">We also provide some functions to perform the correlation between a gene set and immune-related genes, including ICGs (Fig. <xref rid="Fig8" ref-type="fig">8</xref>a), chemokine (Fig. <xref rid="Fig8" ref-type="fig">8</xref>b), chemokine receptor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>c), immune stimulator (Fig. <xref rid="Fig8" ref-type="fig">8</xref>d), and immune inhibitor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>e).<fig id="Fig8"><label>Fig. 8</label><caption><p>Correlation between a gene set and immune-related genes. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and ICGs with function “gs_checkpoint_heatmap("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokines with function “gs_chemokine_heatmap("KEGG_APOPTOSIS")”. <bold>c</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokine receptors with function “gs_receptor_heatmap("KEGG_APOPTOSIS")”. <bold>d</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune stimulators with function “gs_immustimulator_heatmap("KEGG_APOPTOSIS")”. <bold>e</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune inhibitors with function “gs_immuinhibitor_heatmap("KEGG_APOPTOSIS")”</p></caption><graphic xlink:href="12859_2023_5615_Fig8_HTML" id="MO8"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Cancer type specific expression analysis</title>
      <p id="Par27">In addition to pan-cancer analysis, we have also provided numerous functions for caner type specific samples. The expression of a single gene could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>a) and paired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig9" ref-type="fig">9</xref>c, d), gender (Fig. <xref rid="Fig9" ref-type="fig">9</xref>e), and stage (Fig. <xref rid="Fig9" ref-type="fig">9</xref>f).<fig id="Fig9"><label>Fig. 9</label><caption><p>Cancer type specific expression analysis. <bold>a</bold> Expression of KLF7 in COAD with the function “tcga_boxplot("COAD","KLF7")”. <bold>b</bold> Expression of KLF7 in paired COAD samples with the function “paired_boxplot("COAD","KLF7")”. <bold>c</bold> Expression of KLF7 in COAD samples grouped by age with the function “gene_age("COAD","KLF7")”. <bold>d</bold> Expression of KLF7 in COAD samples grouped by three age groups with the function “gene_3age("COAD","KLF7")”. <bold>e</bold> Expression of KLF7 in COAD samples grouped by gender with the function “gene_gender("COAD","KLF7")”. <bold>f</bold> Expression of KLF7 in COAD samples grouped by stage with the function “gene_stage("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig9_HTML" id="MO9"/></fig></p>
      <p id="Par28">Moreover, we provided cancer type specific analysis of gene set. The expression of a gene set could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>a) and paired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig10" ref-type="fig">10</xref>c, d), gender (Fig. <xref rid="Fig10" ref-type="fig">10</xref>e), and stage (Fig. <xref rid="Fig10" ref-type="fig">10</xref>f).<fig id="Fig10"><label>Fig. 10</label><caption><p>Cancer type specific gene set analysis. <bold>a</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD with the function “gs_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>b</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in paired COAD samples with the function “gs_paired_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>c</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by age with the function “gs_age("COAD","HALLMARK_DNA_REPAIR")”. <bold>d</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by three age groups with the function “gs_3age("COAD","HALLMARK_DNA_REPAIR")”. <bold>e</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by gender with the function “gs_gender("COAD","HALLMARK_DNA_REPAIR")”. <bold>f</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by stage with the function “gs_stage("COAD","HALLMARK_DNA_REPAIR")”</p></caption><graphic xlink:href="12859_2023_5615_Fig10_HTML" id="MO10"/></fig></p>
      <p id="Par29">Tumor samples in a specific type of cancer could be further grouped by the expression of a single gene, and the differentially expressed genes (DEGs) between high-expression and low-expression groups could be identified (Fig. <xref rid="Fig11" ref-type="fig">11</xref>a) and analyzed using Gene Set Enrichment Analysis (GSEA) including GSEA-GO (Gene Ontology) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>b) and GSEA-KEGG (Kyoto Encyclopedia of Genes and Genomes) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>c).<fig id="Fig11"><label>Fig. 11</label><caption><p>DEGs analysis between high- and low-expression groups of a single gene. <bold>a</bold> Heat map showed the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_deg_heatmap("COAD","KLF7")”. <bold>b</bold> GSEA-GO analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_go("COAD","KLF7")”, and the top 5 GO pathways were shown. <bold>c</bold> GSEA-KEGG analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_kegg("COAD","KLF7")”, and the top 5 KEGG pathways were shown</p></caption><graphic xlink:href="12859_2023_5615_Fig11_HTML" id="MO11"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Cancer type specific diagnostic analysis</title>
      <p id="Par30">Receiver operating characteristic (ROC) curve and the area under the curve (AUC) were widely used to examine the sensitivity and specificity of a diagnostic model. We provide function to draw the ROC curve and calculate the AUC of a diagnostic model using the expression of a single gene in a specific type of cancer. An example was shown for KLF7 in CHOL (Fig. <xref rid="Fig12" ref-type="fig">12</xref>a), HNSC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>b), and UCEC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>c).<fig id="Fig12"><label>Fig. 12</label><caption><p>Cancer type specific diagnostic analysis. <bold>a</bold> ROC curve of the diagnostic model based on the expression of KLF7 in CHOL with function “tcga_roc("CHOL","KLF7")”. <bold>b</bold> ROC curve of the diagnostic model based on the expression of KLF7 in HNSC with function “tcga_roc("HNSC","KLF7")”. <bold>c</bold> ROC curve of the diagnostic model based on the expression of KLF7 in UCEC with function “tcga_roc("UCEC","KLF7")”. KLF7 showed significant diagnostic values in these types of cancer</p></caption><graphic xlink:href="12859_2023_5615_Fig12_HTML" id="MO12"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Cancer type specific correlation analysis</title>
      <p id="Par31">We provide correlation analysis in a specific type of cancer, including gene–gene (Fig. <xref rid="Fig13" ref-type="fig">13</xref>a, b), gene-methylation (Fig. <xref rid="Fig13" ref-type="fig">13</xref>c) correlation analysis. Moreover, for the correlated genes, GO enrichment analysis (Fig. <xref rid="Fig13" ref-type="fig">13</xref>d) is also available.<fig id="Fig13"><label>Fig. 13</label><caption><p>Cancer type specific correlation analysis. <bold>a</bold> Correlation between KLF4 and KLF7 in COAD with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "F")”. <bold>b</bold> Correlation between KLF4 and KLF7 in COAD showing the density of gene expression with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "T")”. <bold>c</bold> Correlation between KLF7 expression and promoter methylation in COAD with function “gene_methylation_scatter("COAD","KLF7")”. <bold>d</bold> Expression heat map and enriched GO pathways of significantly positive or negative correlated genes with KLF7 in COAD with function “gene_coexp_heatmap("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig13_HTML" id="MO13"/></fig></p>
    </sec>
    <sec id="Sec12">
      <title>Cancer type specific survival analysis</title>
      <p id="Par32">Survival analysis base on the expression (Fig. <xref rid="Fig14" ref-type="fig">14</xref>a) or methylation (Fig. <xref rid="Fig14" ref-type="fig">14</xref>b) level of a single gene in a specific type of cancer could be performed.<fig id="Fig14"><label>Fig. 14</label><caption><p>Cancer type specific survival analysis. <bold>a</bold> KM plot for the survival analysis of KLF7 expression in COAD with function “tcga_kmplot("COAD","KLF7")”. <bold>b</bold> KM plot for the survival analysis of KLF7 methylation in COAD with function “methy_kmplot("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig14_HTML" id="MO14"/></fig></p>
    </sec>
    <sec id="Sec13">
      <title>Network construction</title>
      <p id="Par33">Users can also depict the linkages of a single gene or a gene set and GO terms or KEGG pathways as a network using the gene_network_go (Fig. <xref rid="Fig15" ref-type="fig">15</xref>a) and gene_network_kegg (Fig. <xref rid="Fig15" ref-type="fig">15</xref>b) functions.<fig id="Fig15"><label>Fig. 15</label><caption><p>Network construction. <bold>a</bold> Cnetplot was used to depict the linkages of a gene set and GO terms as a network with function of “gene_network_go(c("LAMA3","LAMC2","TNC","OSMR"))”. <bold>b</bold> Cnetplot was used to depict the linkages of a gene set and KEGG pathways as a network with function of “gene_network_kegg(c("LAMA3","LAMC2","TNC","OSMR"))”</p></caption><graphic xlink:href="12859_2023_5615_Fig15_HTML" id="MO15"/></fig></p>
    </sec>
    <sec id="Sec14">
      <title>Built-in data extraction</title>
      <p id="Par34">All built-in data in our package could be extracted for user-defined functions, including TPM expression matrix, TMB, MSI, immune cell ratio, immune score, promoter methylation, and meta information with functions listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Therefore, users could perform their user-defined functions to make more unique analysis with TCGA multi-omics data.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of functions to extract built-in data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Function name</th><th align="left">Function</th></tr></thead><tbody><tr><td align="left">get_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer in TCGA. eg, get_tpm("COAD")</td></tr><tr><td align="left">get_paired_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer with paired samples (n &gt; 20) in TCGA. eg, get_paired_tpm("COAD")</td></tr><tr><td align="left">get_meta(cancer)</td><td align="left">Extract the clinical information of a specific type of cancer in TCGA. eg, get_meta("COAD")</td></tr><tr><td align="left">get_tmb()</td><td align="left">Extract the TMB matrix of all samples in TCGA</td></tr><tr><td align="left">get_msi()</td><td align="left">Extract the MSI matrix of all samples in TCGA</td></tr><tr><td align="left">get_methy()</td><td align="left">Print the link of the whole methylation matrix for users to download</td></tr><tr><td align="left">get_promoter_methy()</td><td align="left">Extract promoter methylation of a specific type of tumor</td></tr><tr><td align="left">get_immu_ratio()</td><td align="left">Extract the immune cell ratio of all samples in TCGA</td></tr><tr><td align="left">get_immuscore()</td><td align="left">Extract the immune score of all samples in TCGA</td></tr><tr><td align="left">get_cancers()</td><td align="left">Return the sample summary of 33 types of cancer in TCGA</td></tr><tr><td align="left">get_paired_cancers()</td><td align="left">Return the sample summary of 15 types of cancer containing more than 20 paired samples in TCGA</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Conclusion</title>
    <p id="Par35"><italic>TCGAplot</italic> provides a user-friendly interface for analyzing TCGA pan-cancer multi-omics data and uses visualization techniques to enable users explore the commonalities and heterogeneity across numerous types of tumors. Concretely, several functions have been developed to perform pan-cancer paired/unpaired expression analysis, correlation analysis, survival analysis, as well as user-defined function analysis. Overall, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec16">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2023_5615_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1:</bold> The gene lists for “stromal signature” and “immune signature”.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>TME</term>
        <def>
          <p id="Par4">Tumor microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TIME</term>
        <def>
          <p id="Par5">Tumor immune microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p id="Par6">The cancer genome atlas</p>
        </def>
      </def-item>
      <def-item>
        <term>TPM</term>
        <def>
          <p id="Par7">Transcripts per million</p>
        </def>
      </def-item>
      <def-item>
        <term>TMB</term>
        <def>
          <p id="Par8">Tumor mutational burden</p>
        </def>
      </def-item>
      <def-item>
        <term>MSI</term>
        <def>
          <p id="Par9">Microsatellite instability</p>
        </def>
      </def-item>
      <def-item>
        <term>HR</term>
        <def>
          <p id="Par10">Hazard ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>DEGs</term>
        <def>
          <p id="Par11">Differentially expressed genes</p>
        </def>
      </def-item>
      <def-item>
        <term>GSEA</term>
        <def>
          <p id="Par12">Gene set enrichment analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>GO</term>
        <def>
          <p id="Par13">Gene ontology</p>
        </def>
      </def-item>
      <def-item>
        <term>KEGG</term>
        <def>
          <p id="Par14">Kyoto encyclopedia of genes and genomes</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>XW wrote the software and the manuscript. CL prepared the figures. The author read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research was funded by Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2021141 to XW).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The source code is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par36">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par37">Not applicable.</p>
    </notes>
    <notes id="FPar4">
      <title>Availability and requirements</title>
      <p id="Par39">
        <list list-type="bullet">
          <list-item>
            <p id="Par40">Project name TCGAplot</p>
          </list-item>
          <list-item>
            <p id="Par41">Project home page <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link></p>
          </list-item>
          <list-item>
            <p id="Par42">Operating system(s) Platform independent</p>
          </list-item>
          <list-item>
            <p id="Par43">Programming language R</p>
          </list-item>
          <list-item>
            <p id="Par44">License MIT</p>
          </list-item>
          <list-item>
            <p id="Par45">Other requirements: R 2.1.0 or higher</p>
          </list-item>
          <list-item>
            <p id="Par46">Any restrictions to use by non-academics: license needed</p>
          </list-item>
        </list>
      </p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par38">The authors declare that there is no conflict of interest.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2022</article-title>
        <source>CA Cancer J Clin</source>
        <year>2022</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>7</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21708</pub-id>
        <?supplied-pmid 35020204?>
        <pub-id pub-id-type="pmid">35020204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zwierenga</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>van Veggel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>van den Berg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Groen</surname>
            <given-names>HJM</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Groves</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Smit</surname>
            <given-names>EF</given-names>
          </name>
          <name>
            <surname>Hiltermann</surname>
            <given-names>TJN</given-names>
          </name>
          <name>
            <surname>de Langen</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments</article-title>
        <source>Cancer Treat Rev</source>
        <year>2023</year>
        <volume>120</volume>
        <fpage>102628</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ctrv.2023.102628</pub-id>
        <?supplied-pmid 37797348?>
        <pub-id pub-id-type="pmid">37797348</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bejarano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jordao</surname>
            <given-names>MJC</given-names>
          </name>
          <name>
            <surname>Joyce</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic targeting of the tumor microenvironment</article-title>
        <source>Cancer Discov</source>
        <year>2021</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>933</fpage>
        <lpage>959</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-20-1808</pub-id>
        <?supplied-pmid 33811125?>
        <pub-id pub-id-type="pmid">33811125</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zuo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jing</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence-based multi-omics analysis fuels cancer precision medicine</article-title>
        <source>Semin Cancer Biol</source>
        <year>2023</year>
        <volume>88</volume>
        <fpage>187</fpage>
        <lpage>200</lpage>
        <pub-id pub-id-type="doi">10.1016/j.semcancer.2022.12.009</pub-id>
        <?supplied-pmid 36596352?>
        <pub-id pub-id-type="pmid">36596352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Cancer Genome Atlas Research N</collab>
          <name>
            <surname>Weinstein</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Collisson</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Ozenberger</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shmulevich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>10</issue>
        <fpage>1113</fpage>
        <lpage>1120</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2764</pub-id>
        <pub-id pub-id-type="pmid">24071849</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>W1</issue>
        <fpage>W556</fpage>
        <lpage>W560</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz430</pub-id>
        <?supplied-pmid 31114875?>
        <pub-id pub-id-type="pmid">31114875</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cerami</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Sumer</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Aksoy</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Heuer</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title>
        <source>Cancer Discov</source>
        <year>2012</year>
        <volume>2</volume>
        <issue>5</issue>
        <fpage>401</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id>
        <?supplied-pmid 22588877?>
        <pub-id pub-id-type="pmid">22588877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanczky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gyorffy</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Web-based survival analysis tool tailored for medical research (KMplot): development and Implementation</article-title>
        <source>J Med Internet Res</source>
        <year>2021</year>
        <volume>23</volume>
        <issue>7</issue>
        <fpage>e27633</fpage>
        <pub-id pub-id-type="doi">10.2196/27633</pub-id>
        <?supplied-pmid 34309564?>
        <pub-id pub-id-type="pmid">34309564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>YR</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XW</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AY</given-names>
          </name>
        </person-group>
        <article-title>GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels</article-title>
        <source>Brief Bioinform</source>
        <year>2023</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>bbac558</fpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbac558</pub-id>
        <?supplied-pmid 36549921?>
        <pub-id pub-id-type="pmid">36549921</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>TIMER20 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>W1</issue>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <?supplied-pmid 32442275?>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Modhukur</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Iljasenko</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Metsalu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lokk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Laisk-Podar</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vilo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data</article-title>
        <source>Epigenomics</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>277</fpage>
        <lpage>288</lpage>
        <pub-id pub-id-type="doi">10.2217/epi-2017-0118</pub-id>
        <?supplied-pmid 29264942?>
        <pub-id pub-id-type="pmid">29264942</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Colaprico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garofano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cava</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garolini</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sabedot</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Malta</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Pagnotta</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Castiglioni</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>8</issue>
        <fpage>e71</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1507</pub-id>
        <?supplied-pmid 26704973?>
        <pub-id pub-id-type="pmid">26704973</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures</article-title>
        <source>Front Immunol</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>687975</fpage>
        <pub-id pub-id-type="doi">10.3389/fimmu.2021.687975</pub-id>
        <?supplied-pmid 34276676?>
        <pub-id pub-id-type="pmid">34276676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Geistlinger</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schiffer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Azhar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kodali</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Bruijn</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiomic integration of public oncology databases in bioconductor</article-title>
        <source>JCO Clin Cancer Inform</source>
        <year>2020</year>
        <volume>4</volume>
        <fpage>958</fpage>
        <lpage>971</lpage>
        <pub-id pub-id-type="doi">10.1200/CCI.19.00119</pub-id>
        <?supplied-pmid 33119407?>
        <pub-id pub-id-type="pmid">33119407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshihara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shahmoradgoli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vegesna</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Torres-Garcia</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Laird</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>DA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inferring tumour purity and stromal and immune cell admixture from expression data</article-title>
        <source>Nat Commun</source>
        <year>2013</year>
        <volume>4</volume>
        <fpage>2612</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms3612</pub-id>
        <?supplied-pmid 24113773?>
        <pub-id pub-id-type="pmid">24113773</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10726608</article-id>
    <article-id pub-id-type="pmid">38105215</article-id>
    <article-id pub-id-type="publisher-id">5615</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-023-05615-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title><italic>TCGAplot</italic>: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Liao</surname>
          <given-names>Chenqi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Xiong</given-names>
        </name>
        <address>
          <email>wangxiong@tjh.tjmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00p991c53</institution-id><institution-id institution-id-type="GRID">grid.33199.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 7223</institution-id><institution>Tongji Medical College, </institution><institution>Huazhong University of Science and Technology, </institution></institution-wrap>Wuhan, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>12</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>483</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>12</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Pan-cancer analysis examines both the commonalities and heterogeneity among genomic and cellular alterations across numerous types of tumors. Pan-cancer analysis of gene expression, tumor mutational burden (TMB), microsatellite instability (MSI), and tumor immune microenvironment (TIME), and methylation becomes available based on the multi-omics data from The Cancer Genome Atlas Program (TCGA). Some online tools provide analysis of gene and protein expression, mutation, methylation, and survival for TCGA data. However, these online tools were either Uni-functional or were not able to perform analysis of user-defined functions. Therefore, we created the <italic>TCGAplot</italic> R package to facilitate perform pan-cancer analysis and visualization of the built-in multi-omic TCGA data.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2"><italic>TCGAplot</italic> provides several functions to perform pan-cancer paired/unpaired differential gene expression analysis, pan-cancer correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation. Functions for visualization include paired/unpaired boxplot, survival plot, ROC curve, heatmap, scatter, radar chart, and forest plot. Moreover, gene set based pan-cancer and tumor specific analyses were also available. Finally, all these built-in multi-omic data could be extracted for implementation for user-defined functions, making the pan-cancer analysis much more convenient.\</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">We developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. The source code and pre-built package are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12859-023-05615-3.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>TCGAplot</kwd>
      <kwd>TCGA</kwd>
      <kwd>Pan-cancer analysis</kwd>
      <kwd>Visualization</kwd>
      <kwd>User-defined function</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>
        </funding-source>
        <award-id>2021141</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wang</surname>
            <given-names>Xiong</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par15">Cancer is a major public health problem and leading death causes worldwide, with increasing new cases and deaths each year [<xref ref-type="bibr" rid="CR1">1</xref>]. Tumor occurrence and progression are accompanied by dysregulation of oncogene and tumor suppressor genes partially caused by mutation, promoter and gene body methylation [<xref ref-type="bibr" rid="CR2">2</xref>]. Immune escape is one of the most essential hallmarks of cancer cells which evade immune surveillance via disrupt the crosstalk with immune cells within the tumor microenvironment (TME). TME and tumor immune microenvironment (TIME) attract much attention in cancer research area, and strategies targeting TME have emerged as promising approaches for cancer treatment [<xref ref-type="bibr" rid="CR3">3</xref>]. Advances in multi-omics technologies enable us to access multi-layer information from the genome, transcriptome, proteome, metabolome, and epigenome, fueling the development of cancer precision medicine [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
    <p id="Par16">The Cancer Genome Atlas (TCGA) is one of the largest collections of multi-omics data involving 33 different types of cancer for more than 20 000 samples, including exome sequencing, RNA sequencing, microRNA sequencing, copy number variation, proteome and methylome [<xref ref-type="bibr" rid="CR5">5</xref>]. Several online tools have been developed to provide bioinformatic analysis of TCGA data. Tang et al. [<xref ref-type="bibr" rid="CR6">6</xref>] developed the web server GEPIA2 to perform gene expression quantification at both pan-cancer level and a specific cancer subtype manner. The cBioPortal (<ext-link ext-link-type="uri" xlink:href="https://www.cbioportal.org/">https://www.cbioportal.org/</ext-link>) for Cancer Genomics contains data sets from numerous cancer studies including TCGA, and enables researchers to explore genetic alterations per gene and sample [<xref ref-type="bibr" rid="CR7">7</xref>]. Kaplan–Meier plotter (<ext-link ext-link-type="uri" xlink:href="http://kmplot.com/analysis/">http://kmplot.com/analysis/</ext-link>) provides pan-cancer survival analysis [<xref ref-type="bibr" rid="CR8">8</xref>]. Gene Set Cancer Analysis (GSCA, <ext-link ext-link-type="uri" xlink:href="http://bioinfo.life.hust.edu.cn/GSCA/">http://bioinfo.life.hust.edu.cn/GSCA/</ext-link>#/) provides gene set cancer analysis for TCGA data, including genomic, pharmacogenomic, and immunogenomic gene sets [<xref ref-type="bibr" rid="CR9">9</xref>]. TIMER2.0 is a web server for immune infiltration across TCGA cancers [<xref ref-type="bibr" rid="CR10">10</xref>]. MethSurv (<ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/methsurv/">https://biit.cs.ut.ee/methsurv/</ext-link>) provides a web tool to perform survival analysis using TCGA methylome data [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition to these online website tools, some R packages have been developed for TCGA data download, genomic and expressive analysis, such as TCGAbiolinks and IBOR [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, an integrative R package for pan-cancer expression and correlation analysis between gene expression and TMB, MSI, TIME, and promoter methylation, is not available yet. Therefore, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA data named <italic>TCGAplot</italic>.</p>
    <sec id="Sec2">
      <title>Implementation</title>
      <p id="Par17">The source code of <italic>TCGAplot</italic> R package is public available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>. A pre-built version (v4.0.0) could be downloaded (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip">https://github.com/tjhwangxiong/TCGAplot/releases/download/v4.0.0/TCGAplot_4.0.0.zip</ext-link>) and installed quickly. A detailed vignette is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd">https://github.com/tjhwangxiong/TCGAplot/blob/main/vignettes/TCGAplot.Rmd</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec3">
    <title>Results</title>
    <sec id="Sec4">
      <title>Data preparation</title>
      <p id="Par18">The integrated built-in data in <italic>TCGAplot</italic> R package include TPM (transcripts per million) expression matrix, tumor mutational burden (TMB), microsatellite instability (MSI), immune cell ratio, immune score, promoter methylation, and meta information (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of built-in data in <italic>TCGAplot</italic> R package. Both paired and unpaired TPM matrixes were included. Meta, TMB, MSI, promoter methylation, immune cell ratio, and immune scores were also included in this data. All these built-in data could be extracted for user-defined functions</p></caption><graphic xlink:href="12859_2023_5615_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">The expression TPM matrix was downloaded from TCGA (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</ext-link>) using the TCGAbiolinks R package (v2.28.4) with GDCquery, GDCdownload, and GDCprepare functions [<xref ref-type="bibr" rid="CR12">12</xref>]. Duplicated samples were removed randomly. Genes with TPM value of 0 across all samples were excluded, and the final TPM matrix with protein-coding genes was shown as log2(TPM + 1) accompanied with cancer type and group (tumor, normal) information. The somatic mutation and DNA methylation beta value data were downloaded with the TCGAbiolinks R package. The probes within the TSS1500-island region was selected as promoter region. The MSI value of TCGA patients were downloaded using the cBioPortalData R package (v2.12.0) [<xref ref-type="bibr" rid="CR14">14</xref>]. The immune cell ratio was downloaded from The Immune Landscape of Cancer (<ext-link ext-link-type="uri" xlink:href="https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a">https://api.gdc.cancer.gov/data/b3df502e-3594-46ef-9f94-d041a20a0b9a</ext-link>). The immune scores, including ESTIMATE, Immune, and Stromal scores, were calculated using the estimate R package (v1.0.13) based on the TPM matrix [<xref ref-type="bibr" rid="CR15">15</xref>]. The gene lists for ‘stromal signature’ and ‘immune signature’ were summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
    </sec>
    <sec id="Sec5">
      <title>Pan-cancer expression analysis</title>
      <p id="Par20">Pan-cancer expression analysis includes unpaired tumor-normal box plot across 33 types of TCGA cancers (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a) and paired tumor-normal box plot across 15 types of TCGA cancers with more than 20 pairs of samples (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b) using pan_boxplot and pan_paired_boxplot functions respectively. Moreover, pan-cancer expression of a single gene across 33 types of tumor samples (without normal samples) could be achieved by using pan_tumor_boxplot function (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c).<fig id="Fig2"><label>Fig. 2</label><caption><p>Pan-cancer expression analysis. <bold>a</bold> Pan-cancer expression of KLF7 with the function of “pan_boxplot(gene = "KLF7", palette = "jco", legend = "right")”. <bold>b</bold> Pan-cancer expression of KLF7 of paired samples with the function of “pan_paired_boxplot (gene = "KLF7", palette = "jco", legend = "right")”. Only 15 types of cancers with more than 20 paired samples in TCGA were included. <bold>c</bold> Pan-cancer expression of KLF7 across 33 types of tumor samples (without normal samples) with the function of “pan_tumor_boxplot("KLF7")”. ns, not significant; *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001</p></caption><graphic xlink:href="12859_2023_5615_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>Pan-cancer correlation analysis</title>
      <p id="Par21">We also provide functions to analyze the correlation between single gene expression and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b).<fig id="Fig3"><label>Fig. 3</label><caption><p>Correlation between gene expression and TMB, and MSI. <bold>a</bold> Correlation between expression of KLF7 and TMB with the function “gene_TMB_radar("KLF7")”. KLF7 was negatively correlated with TMB in CHOL, COAD, ESCA, HNSC, KIRP, OV, and THCA, while positively correlated with TMB in SKCM. <bold>b</bold> Correlation between expression of KLF7 and MSI with the function “gene_MSI_radar("KLF7")”. KLF7 was negatively correlated with MSI in COAD, DLBC, HNSC, and STAD, while positively correlated with MSI in LUSC. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par22">Immunotherapy has revolutionized the treatment of cancer patients and rejuvenated the field of TIME. Therefore, we also provide some functions to perform the correlation between a single gene and immune-related genes, including immune checkpoint genes (ICGs) (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a), chemokine (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b), chemokine receptor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c), immune stimulator (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d), and immune inhibitor (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e). Moreover, two color parameters, “lowcol” and “highcol”, were provided for users to define the colors of low point and high point in the heatmap respectively.<fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between a single gene and immune-related genes. <bold>a</bold> Correlation between KLF7 and ICGs with function “gene_checkpoint_heatmap("KLF7", method = "pearson", lowcol = "blue", highcol = "red")”. <bold>b</bold> Correlation between KLF7 and chemokines with function “gene_chemokine_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and chemokine receptors with function “gene_receptor_heatmap("KLF7")”. <bold>d</bold> Correlation between KLF7 and immune stimulators with function “gene_immustimulator_heatmap("KLF7")”. <bold>e</bold> Correlation between KLF7 and immune inhibitors with function “gene_immuinhibitor_heatmap("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par23">Moreover, correlation between gene expression and immune infiltration could be analyzed, including immune cell ratio (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a), immune score (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b, c).<fig id="Fig5"><label>Fig. 5</label><caption><p>Correlation a single gene and immune infiltration. <bold>a</bold> Correlation between KLF7 and immune cell ratio with function “gene_immucell_heatmap("KLF7")”. <bold>b</bold> Correlation between KLF7 and immune score displayed by heatmap with function “gene_immunescore_heatmap("KLF7")”. <bold>c</bold> Correlation between KLF7 and immune score displayed by triangle with function “gene_immunescore_triangle("KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Pan-cancer cox regression analysis</title>
      <p id="Par24">The Cox regression model is used for survival analyses in clinical research by estimating the hazard ratio (HR) of a given endpoint correlated with a specific risk factor, such as the expression of a single gene. We provide function to perform pan-cancer cox regression analysis with or without age adjustment and visualization by forest plot (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a, b).<fig id="Fig6"><label>Fig. 6</label><caption><p>Pan-cancer Cox regression analysis. <bold>a</bold> Pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = F)”. KLF7 acts as risk factor in CESE, HNSC, LGG, PAAD, while acts as protective factor in KIRC and READ. <bold>b</bold> Age adjusted pan-cancer Cox regression analysis of KLF7 across TCGA cancers with function “pan_forest("KLF7", adjust = T)”. After age adjustment, KLF7 did not act as a protective factor in READ</p></caption><graphic xlink:href="12859_2023_5615_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Pan-cancer correlation analysis based on gene set</title>
      <p id="Par25">Sometimes it is a gene set (instead of a gene) that’s driving the TMB, so we also provide functions to analyze the correlation between the express of a gene set and TMB, and MSI. The results were visualized with radar chart (Fig. <xref rid="Fig7" ref-type="fig">7</xref>a, b).<fig id="Fig7"><label>Fig. 7</label><caption><p>Correlation between gene set and TMB, and MSI. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and TMB with the function “gs_TMB_radar("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and MSI with the function “gs_MSI_radar("KEGG_APOPTOSIS")”. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</p></caption><graphic xlink:href="12859_2023_5615_Fig7_HTML" id="MO7"/></fig></p>
      <p id="Par26">We also provide some functions to perform the correlation between a gene set and immune-related genes, including ICGs (Fig. <xref rid="Fig8" ref-type="fig">8</xref>a), chemokine (Fig. <xref rid="Fig8" ref-type="fig">8</xref>b), chemokine receptor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>c), immune stimulator (Fig. <xref rid="Fig8" ref-type="fig">8</xref>d), and immune inhibitor (Fig. <xref rid="Fig8" ref-type="fig">8</xref>e).<fig id="Fig8"><label>Fig. 8</label><caption><p>Correlation between a gene set and immune-related genes. <bold>a</bold> Correlation between the gene set of KEGG_APOPTOSIS and ICGs with function “gs_checkpoint_heatmap("KEGG_APOPTOSIS")”. <bold>b</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokines with function “gs_chemokine_heatmap("KEGG_APOPTOSIS")”. <bold>c</bold> Correlation between the gene set of KEGG_APOPTOSIS and chemokine receptors with function “gs_receptor_heatmap("KEGG_APOPTOSIS")”. <bold>d</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune stimulators with function “gs_immustimulator_heatmap("KEGG_APOPTOSIS")”. <bold>e</bold> Correlation between the gene set of KEGG_APOPTOSIS and immune inhibitors with function “gs_immuinhibitor_heatmap("KEGG_APOPTOSIS")”</p></caption><graphic xlink:href="12859_2023_5615_Fig8_HTML" id="MO8"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Cancer type specific expression analysis</title>
      <p id="Par27">In addition to pan-cancer analysis, we have also provided numerous functions for caner type specific samples. The expression of a single gene could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>a) and paired (Fig. <xref rid="Fig9" ref-type="fig">9</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig9" ref-type="fig">9</xref>c, d), gender (Fig. <xref rid="Fig9" ref-type="fig">9</xref>e), and stage (Fig. <xref rid="Fig9" ref-type="fig">9</xref>f).<fig id="Fig9"><label>Fig. 9</label><caption><p>Cancer type specific expression analysis. <bold>a</bold> Expression of KLF7 in COAD with the function “tcga_boxplot("COAD","KLF7")”. <bold>b</bold> Expression of KLF7 in paired COAD samples with the function “paired_boxplot("COAD","KLF7")”. <bold>c</bold> Expression of KLF7 in COAD samples grouped by age with the function “gene_age("COAD","KLF7")”. <bold>d</bold> Expression of KLF7 in COAD samples grouped by three age groups with the function “gene_3age("COAD","KLF7")”. <bold>e</bold> Expression of KLF7 in COAD samples grouped by gender with the function “gene_gender("COAD","KLF7")”. <bold>f</bold> Expression of KLF7 in COAD samples grouped by stage with the function “gene_stage("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig9_HTML" id="MO9"/></fig></p>
      <p id="Par28">Moreover, we provided cancer type specific analysis of gene set. The expression of a gene set could be grouped by clinical data, including unpaired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>a) and paired (Fig. <xref rid="Fig10" ref-type="fig">10</xref>b) tumor-normal samples, age (Fig. <xref rid="Fig10" ref-type="fig">10</xref>c, d), gender (Fig. <xref rid="Fig10" ref-type="fig">10</xref>e), and stage (Fig. <xref rid="Fig10" ref-type="fig">10</xref>f).<fig id="Fig10"><label>Fig. 10</label><caption><p>Cancer type specific gene set analysis. <bold>a</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD with the function “gs_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>b</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in paired COAD samples with the function “gs_paired_boxplot("COAD","HALLMARK_DNA_REPAIR")”. <bold>c</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by age with the function “gs_age("COAD","HALLMARK_DNA_REPAIR")”. <bold>d</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by three age groups with the function “gs_3age("COAD","HALLMARK_DNA_REPAIR")”. <bold>e</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by gender with the function “gs_gender("COAD","HALLMARK_DNA_REPAIR")”. <bold>f</bold> Expression of the gene set "HALLMARK_DNA_REPAIR" in COAD samples grouped by stage with the function “gs_stage("COAD","HALLMARK_DNA_REPAIR")”</p></caption><graphic xlink:href="12859_2023_5615_Fig10_HTML" id="MO10"/></fig></p>
      <p id="Par29">Tumor samples in a specific type of cancer could be further grouped by the expression of a single gene, and the differentially expressed genes (DEGs) between high-expression and low-expression groups could be identified (Fig. <xref rid="Fig11" ref-type="fig">11</xref>a) and analyzed using Gene Set Enrichment Analysis (GSEA) including GSEA-GO (Gene Ontology) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>b) and GSEA-KEGG (Kyoto Encyclopedia of Genes and Genomes) (Fig. <xref rid="Fig11" ref-type="fig">11</xref>c).<fig id="Fig11"><label>Fig. 11</label><caption><p>DEGs analysis between high- and low-expression groups of a single gene. <bold>a</bold> Heat map showed the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_deg_heatmap("COAD","KLF7")”. <bold>b</bold> GSEA-GO analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_go("COAD","KLF7")”, and the top 5 GO pathways were shown. <bold>c</bold> GSEA-KEGG analysis of the DEGs between KLF7 high- and low-expression groups in COAD with function “gene_gsea_kegg("COAD","KLF7")”, and the top 5 KEGG pathways were shown</p></caption><graphic xlink:href="12859_2023_5615_Fig11_HTML" id="MO11"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Cancer type specific diagnostic analysis</title>
      <p id="Par30">Receiver operating characteristic (ROC) curve and the area under the curve (AUC) were widely used to examine the sensitivity and specificity of a diagnostic model. We provide function to draw the ROC curve and calculate the AUC of a diagnostic model using the expression of a single gene in a specific type of cancer. An example was shown for KLF7 in CHOL (Fig. <xref rid="Fig12" ref-type="fig">12</xref>a), HNSC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>b), and UCEC (Fig. <xref rid="Fig12" ref-type="fig">12</xref>c).<fig id="Fig12"><label>Fig. 12</label><caption><p>Cancer type specific diagnostic analysis. <bold>a</bold> ROC curve of the diagnostic model based on the expression of KLF7 in CHOL with function “tcga_roc("CHOL","KLF7")”. <bold>b</bold> ROC curve of the diagnostic model based on the expression of KLF7 in HNSC with function “tcga_roc("HNSC","KLF7")”. <bold>c</bold> ROC curve of the diagnostic model based on the expression of KLF7 in UCEC with function “tcga_roc("UCEC","KLF7")”. KLF7 showed significant diagnostic values in these types of cancer</p></caption><graphic xlink:href="12859_2023_5615_Fig12_HTML" id="MO12"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Cancer type specific correlation analysis</title>
      <p id="Par31">We provide correlation analysis in a specific type of cancer, including gene–gene (Fig. <xref rid="Fig13" ref-type="fig">13</xref>a, b), gene-methylation (Fig. <xref rid="Fig13" ref-type="fig">13</xref>c) correlation analysis. Moreover, for the correlated genes, GO enrichment analysis (Fig. <xref rid="Fig13" ref-type="fig">13</xref>d) is also available.<fig id="Fig13"><label>Fig. 13</label><caption><p>Cancer type specific correlation analysis. <bold>a</bold> Correlation between KLF4 and KLF7 in COAD with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "F")”. <bold>b</bold> Correlation between KLF4 and KLF7 in COAD showing the density of gene expression with function “gene_gene_scatter("COAD","KLF4","KLF7", density = "T")”. <bold>c</bold> Correlation between KLF7 expression and promoter methylation in COAD with function “gene_methylation_scatter("COAD","KLF7")”. <bold>d</bold> Expression heat map and enriched GO pathways of significantly positive or negative correlated genes with KLF7 in COAD with function “gene_coexp_heatmap("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig13_HTML" id="MO13"/></fig></p>
    </sec>
    <sec id="Sec12">
      <title>Cancer type specific survival analysis</title>
      <p id="Par32">Survival analysis base on the expression (Fig. <xref rid="Fig14" ref-type="fig">14</xref>a) or methylation (Fig. <xref rid="Fig14" ref-type="fig">14</xref>b) level of a single gene in a specific type of cancer could be performed.<fig id="Fig14"><label>Fig. 14</label><caption><p>Cancer type specific survival analysis. <bold>a</bold> KM plot for the survival analysis of KLF7 expression in COAD with function “tcga_kmplot("COAD","KLF7")”. <bold>b</bold> KM plot for the survival analysis of KLF7 methylation in COAD with function “methy_kmplot("COAD","KLF7")”</p></caption><graphic xlink:href="12859_2023_5615_Fig14_HTML" id="MO14"/></fig></p>
    </sec>
    <sec id="Sec13">
      <title>Network construction</title>
      <p id="Par33">Users can also depict the linkages of a single gene or a gene set and GO terms or KEGG pathways as a network using the gene_network_go (Fig. <xref rid="Fig15" ref-type="fig">15</xref>a) and gene_network_kegg (Fig. <xref rid="Fig15" ref-type="fig">15</xref>b) functions.<fig id="Fig15"><label>Fig. 15</label><caption><p>Network construction. <bold>a</bold> Cnetplot was used to depict the linkages of a gene set and GO terms as a network with function of “gene_network_go(c("LAMA3","LAMC2","TNC","OSMR"))”. <bold>b</bold> Cnetplot was used to depict the linkages of a gene set and KEGG pathways as a network with function of “gene_network_kegg(c("LAMA3","LAMC2","TNC","OSMR"))”</p></caption><graphic xlink:href="12859_2023_5615_Fig15_HTML" id="MO15"/></fig></p>
    </sec>
    <sec id="Sec14">
      <title>Built-in data extraction</title>
      <p id="Par34">All built-in data in our package could be extracted for user-defined functions, including TPM expression matrix, TMB, MSI, immune cell ratio, immune score, promoter methylation, and meta information with functions listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Therefore, users could perform their user-defined functions to make more unique analysis with TCGA multi-omics data.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of functions to extract built-in data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Function name</th><th align="left">Function</th></tr></thead><tbody><tr><td align="left">get_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer in TCGA. eg, get_tpm("COAD")</td></tr><tr><td align="left">get_paired_tpm(cancer)</td><td align="left">Extract the TPM matrix of a specific type of cancer with paired samples (n &gt; 20) in TCGA. eg, get_paired_tpm("COAD")</td></tr><tr><td align="left">get_meta(cancer)</td><td align="left">Extract the clinical information of a specific type of cancer in TCGA. eg, get_meta("COAD")</td></tr><tr><td align="left">get_tmb()</td><td align="left">Extract the TMB matrix of all samples in TCGA</td></tr><tr><td align="left">get_msi()</td><td align="left">Extract the MSI matrix of all samples in TCGA</td></tr><tr><td align="left">get_methy()</td><td align="left">Print the link of the whole methylation matrix for users to download</td></tr><tr><td align="left">get_promoter_methy()</td><td align="left">Extract promoter methylation of a specific type of tumor</td></tr><tr><td align="left">get_immu_ratio()</td><td align="left">Extract the immune cell ratio of all samples in TCGA</td></tr><tr><td align="left">get_immuscore()</td><td align="left">Extract the immune score of all samples in TCGA</td></tr><tr><td align="left">get_cancers()</td><td align="left">Return the sample summary of 33 types of cancer in TCGA</td></tr><tr><td align="left">get_paired_cancers()</td><td align="left">Return the sample summary of 15 types of cancer containing more than 20 paired samples in TCGA</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Conclusion</title>
    <p id="Par35"><italic>TCGAplot</italic> provides a user-friendly interface for analyzing TCGA pan-cancer multi-omics data and uses visualization techniques to enable users explore the commonalities and heterogeneity across numerous types of tumors. Concretely, several functions have been developed to perform pan-cancer paired/unpaired expression analysis, correlation analysis, survival analysis, as well as user-defined function analysis. Overall, we developed an R-package for integrative pan-cancer analysis and visualization of TCGA multi-omics data.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec16">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2023_5615_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1:</bold> The gene lists for “stromal signature” and “immune signature”.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>TME</term>
        <def>
          <p id="Par4">Tumor microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TIME</term>
        <def>
          <p id="Par5">Tumor immune microenvironment</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p id="Par6">The cancer genome atlas</p>
        </def>
      </def-item>
      <def-item>
        <term>TPM</term>
        <def>
          <p id="Par7">Transcripts per million</p>
        </def>
      </def-item>
      <def-item>
        <term>TMB</term>
        <def>
          <p id="Par8">Tumor mutational burden</p>
        </def>
      </def-item>
      <def-item>
        <term>MSI</term>
        <def>
          <p id="Par9">Microsatellite instability</p>
        </def>
      </def-item>
      <def-item>
        <term>HR</term>
        <def>
          <p id="Par10">Hazard ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>DEGs</term>
        <def>
          <p id="Par11">Differentially expressed genes</p>
        </def>
      </def-item>
      <def-item>
        <term>GSEA</term>
        <def>
          <p id="Par12">Gene set enrichment analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>GO</term>
        <def>
          <p id="Par13">Gene ontology</p>
        </def>
      </def-item>
      <def-item>
        <term>KEGG</term>
        <def>
          <p id="Par14">Kyoto encyclopedia of genes and genomes</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>XW wrote the software and the manuscript. CL prepared the figures. The author read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research was funded by Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2021141 to XW).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The source code is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link>).</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par36">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par37">Not applicable.</p>
    </notes>
    <notes id="FPar4">
      <title>Availability and requirements</title>
      <p id="Par39">
        <list list-type="bullet">
          <list-item>
            <p id="Par40">Project name TCGAplot</p>
          </list-item>
          <list-item>
            <p id="Par41">Project home page <ext-link ext-link-type="uri" xlink:href="https://github.com/tjhwangxiong/TCGAplot">https://github.com/tjhwangxiong/TCGAplot</ext-link></p>
          </list-item>
          <list-item>
            <p id="Par42">Operating system(s) Platform independent</p>
          </list-item>
          <list-item>
            <p id="Par43">Programming language R</p>
          </list-item>
          <list-item>
            <p id="Par44">License MIT</p>
          </list-item>
          <list-item>
            <p id="Par45">Other requirements: R 2.1.0 or higher</p>
          </list-item>
          <list-item>
            <p id="Par46">Any restrictions to use by non-academics: license needed</p>
          </list-item>
        </list>
      </p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par38">The authors declare that there is no conflict of interest.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2022</article-title>
        <source>CA Cancer J Clin</source>
        <year>2022</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>7</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21708</pub-id>
        <?supplied-pmid 35020204?>
        <pub-id pub-id-type="pmid">35020204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zwierenga</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>van Veggel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>van den Berg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Groen</surname>
            <given-names>HJM</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Groves</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Smit</surname>
            <given-names>EF</given-names>
          </name>
          <name>
            <surname>Hiltermann</surname>
            <given-names>TJN</given-names>
          </name>
          <name>
            <surname>de Langen</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments</article-title>
        <source>Cancer Treat Rev</source>
        <year>2023</year>
        <volume>120</volume>
        <fpage>102628</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ctrv.2023.102628</pub-id>
        <?supplied-pmid 37797348?>
        <pub-id pub-id-type="pmid">37797348</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bejarano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jordao</surname>
            <given-names>MJC</given-names>
          </name>
          <name>
            <surname>Joyce</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic targeting of the tumor microenvironment</article-title>
        <source>Cancer Discov</source>
        <year>2021</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>933</fpage>
        <lpage>959</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-20-1808</pub-id>
        <?supplied-pmid 33811125?>
        <pub-id pub-id-type="pmid">33811125</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zuo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jing</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence-based multi-omics analysis fuels cancer precision medicine</article-title>
        <source>Semin Cancer Biol</source>
        <year>2023</year>
        <volume>88</volume>
        <fpage>187</fpage>
        <lpage>200</lpage>
        <pub-id pub-id-type="doi">10.1016/j.semcancer.2022.12.009</pub-id>
        <?supplied-pmid 36596352?>
        <pub-id pub-id-type="pmid">36596352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>Cancer Genome Atlas Research N</collab>
          <name>
            <surname>Weinstein</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Collisson</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Ozenberger</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shmulevich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>10</issue>
        <fpage>1113</fpage>
        <lpage>1120</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2764</pub-id>
        <pub-id pub-id-type="pmid">24071849</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>W1</issue>
        <fpage>W556</fpage>
        <lpage>W560</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz430</pub-id>
        <?supplied-pmid 31114875?>
        <pub-id pub-id-type="pmid">31114875</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cerami</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Sumer</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Aksoy</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Heuer</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title>
        <source>Cancer Discov</source>
        <year>2012</year>
        <volume>2</volume>
        <issue>5</issue>
        <fpage>401</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id>
        <?supplied-pmid 22588877?>
        <pub-id pub-id-type="pmid">22588877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lanczky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gyorffy</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Web-based survival analysis tool tailored for medical research (KMplot): development and Implementation</article-title>
        <source>J Med Internet Res</source>
        <year>2021</year>
        <volume>23</volume>
        <issue>7</issue>
        <fpage>e27633</fpage>
        <pub-id pub-id-type="doi">10.2196/27633</pub-id>
        <?supplied-pmid 34309564?>
        <pub-id pub-id-type="pmid">34309564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>GY</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>YR</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XW</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>AY</given-names>
          </name>
        </person-group>
        <article-title>GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels</article-title>
        <source>Brief Bioinform</source>
        <year>2023</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>bbac558</fpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbac558</pub-id>
        <?supplied-pmid 36549921?>
        <pub-id pub-id-type="pmid">36549921</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>TIMER20 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>W1</issue>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <?supplied-pmid 32442275?>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Modhukur</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Iljasenko</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Metsalu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lokk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Laisk-Podar</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vilo</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data</article-title>
        <source>Epigenomics</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>277</fpage>
        <lpage>288</lpage>
        <pub-id pub-id-type="doi">10.2217/epi-2017-0118</pub-id>
        <?supplied-pmid 29264942?>
        <pub-id pub-id-type="pmid">29264942</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Colaprico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Olsen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garofano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cava</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garolini</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sabedot</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Malta</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Pagnotta</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Castiglioni</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>8</issue>
        <fpage>e71</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv1507</pub-id>
        <?supplied-pmid 26704973?>
        <pub-id pub-id-type="pmid">26704973</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures</article-title>
        <source>Front Immunol</source>
        <year>2021</year>
        <volume>12</volume>
        <fpage>687975</fpage>
        <pub-id pub-id-type="doi">10.3389/fimmu.2021.687975</pub-id>
        <?supplied-pmid 34276676?>
        <pub-id pub-id-type="pmid">34276676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Geistlinger</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schiffer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Azhar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kodali</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Bruijn</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiomic integration of public oncology databases in bioconductor</article-title>
        <source>JCO Clin Cancer Inform</source>
        <year>2020</year>
        <volume>4</volume>
        <fpage>958</fpage>
        <lpage>971</lpage>
        <pub-id pub-id-type="doi">10.1200/CCI.19.00119</pub-id>
        <?supplied-pmid 33119407?>
        <pub-id pub-id-type="pmid">33119407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshihara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shahmoradgoli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vegesna</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Torres-Garcia</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Laird</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>DA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inferring tumour purity and stromal and immune cell admixture from expression data</article-title>
        <source>Nat Commun</source>
        <year>2013</year>
        <volume>4</volume>
        <fpage>2612</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms3612</pub-id>
        <?supplied-pmid 24113773?>
        <pub-id pub-id-type="pmid">24113773</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
